Skip to main content
Log in

Von Weinsäure zu Weinbeere – eine ungewöhnliche Form der Ösophagitis

From Tartaric Acid to Grapes—An Unusual Form of Esophagitis

  • Fallbericht
  • Published:
Journal für Gastroenterologische und Hepatologische Erkrankungen Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Abbreviations

CMV:

Zytomegalievirus

HSV:

Herpes-simplex-Virus

PCR:

Polymerasekettenreaktion

Literatur

  1. Grossi L, Ciccaglione AF, Marzio L (2017) Esophagitis and its causes: who is “guilty” when acid is found “not guilty”? World J Gastroenterol 23(17):3011–3016. https://doi.org/10.3748/wjg.v23.i17.3011

    Article  PubMed  PubMed Central  Google Scholar 

  2. Scheppach W, Meesmann M (2015) Exfoliative esophagitis while taking dabigatran. Dtsch Med Wochenschr 140(7):515–518. https://doi.org/10.1055/s-0041-101313

    Article  PubMed  Google Scholar 

  3. Kim SH, Jeong JB, Kim JW, Koh SJ, Kim BG, Lee KL, Chang MS, Im JP, Kang HW, Shin CM (2014) Clinical and endoscopic characteristics of drug-induced esophagitis. World J Gastroenterol 20(31):10994–10999. https://doi.org/10.3748/wjg.v20.i31.10994

    Article  PubMed  PubMed Central  Google Scholar 

  4. Davila M, Bresalier RS (2008) Gastrointestinal complications of oncologic therapy. Nat Clin Pract Gastroenterol Hepatol 5(12):682–696. https://doi.org/10.1038/ncpgasthep1277

    Article  PubMed  Google Scholar 

  5. Boyce HW Jr. (1998) Drug-induced esophageal damage: diseases of medical progress. Gastrointest Endosc 47(6):547–550. https://doi.org/10.1016/s0016-5107(98)70264-0

    Article  PubMed  Google Scholar 

  6. Jaspersen D (2000) Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf 22(3):237–249. https://doi.org/10.2165/00002018-200022030-00007

    Article  CAS  PubMed  Google Scholar 

  7. Becker B, Borovicka J, Zimmermann D (2014) Dabigatran-induzierte exfoliative Ösophagitis. Eine (noch?) seltene Manifestation von Thoraxschmerzen. Schweiz Med Forum 14(43):802–804

    Google Scholar 

  8. Frieling T (2018) Non-cardiac chest pain. Visc Med 34(2):92–96. https://doi.org/10.1159/000486440

    Article  PubMed  PubMed Central  Google Scholar 

  9. Mueller S, Aigner T, Neureiter D, Stolte M (2006) Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy. J Clin Pathol 59(11):1175–1180. https://doi.org/10.1136/jcp.2005.031922

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Saleem F, Sharma A (2022) Drug induced esophagitis. In: StatPearls. StatPearls Publishing, Treasure Island

    Google Scholar 

  11. Bordea MA, Pirvan A, Sarban C, Margescu C, Leucuta D, Samasca G, Miu N (2014) Pill-induced erosive esophagitis in children. Clujul Med 87(1):15–18. https://doi.org/10.15386/cjm.2014.8872.871.mab1

    Article  PubMed  PubMed Central  Google Scholar 

  12. Okada M, Okada K (2012) Exfoliative esophagitis and esophageal ulcer induced by dabigatran. Endoscopy 44(Suppl 2):E23–E24. https://doi.org/10.1055/s-0031-1291503

    Article  PubMed  Google Scholar 

  13. Toya Y, Nakamura S, Tomita K, Matsuda N, Abe K, Abiko Y, Orikasa S, Akasaka R, Chiba T, Uesugi N, Sugai T, Matsumoto T (2016) Dabigatran-induced esophagitis: the prevalence and endoscopic characteristics. J Gastroenterol Hepatol 31(3):610–614. https://doi.org/10.1111/jgh.13024

    Article  CAS  PubMed  Google Scholar 

  14. Zhang N, Liu XS, Li G, Liu T (2016) Dabigatran-induced esophagitis: a frequently overlooked adverse effect. Int J Cardiol 212:358–359. https://doi.org/10.1016/j.ijcard.2016.03.178

    Article  PubMed  Google Scholar 

  15. Zhou Y, Dai Y, Lu L, Fu Z (2020) Dabigatran-induced esophagitis: a case report. Medicine 99(17):e19890. https://doi.org/10.1097/MD.0000000000019890

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lin S, Wang Y, Zhang L, Guan W (2019) Dabigatran must be used carefully: literature review and recommendations for management of adverse events. Drug Des Devel Ther 13:1527–1533. https://doi.org/10.2147/dddt.S203112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zografos GN, Georgiadou D, Thomas D, Kaltsas G, Digalakis M (2009) Drug-induced esophagitis. Dis Esophagus 22(8):633–637. https://doi.org/10.1111/j.1442-2050.2009.00972.x

    Article  CAS  PubMed  Google Scholar 

  18. Argueta EA, Pan J, Fine S (2020) An unusual case of esophagitis. Gastroenterology 158(1):e3–e4. https://doi.org/10.1053/j.gastro.2019.07.024

    Article  PubMed  Google Scholar 

  19. Shibagaki K, Taniguchi H, Goto D, Kobayashi K, Kinoshita Y (2016) Dabigatran-induced asymptomatic esophageal mucosal injury. Gastrointest Endosc 83(2):472–473. https://doi.org/10.1016/j.gie.2015.08.028 (discussion 474)

    Article  PubMed  Google Scholar 

  20. Ootani A, Hayashi Y, Miyagi Y (2014) Dabigatran-induced esophagitis. Clin Gastroenterol Hepatol 12(7):e55–e56. https://doi.org/10.1016/j.cgh.2013.09.010

    Article  PubMed  Google Scholar 

  21. Fujikawa K, Takasugi N, Goto T, Minatoguchi S (2017) Very late-onset dabigatran-induced esophageal injury. Can J Cardiol 33(4):554.e15–554.e16. https://doi.org/10.1016/j.cjca

    Article  PubMed  Google Scholar 

  22. Kajihara Y (2019) Dabigatran-induced esophagitis. Cleve Clin J Med 86(5):303–304. https://doi.org/10.3949/ccjm.86a.18117

    Article  PubMed  Google Scholar 

  23. Iwamuro M, Matsushita H, Tanaka T, Okada H (2021) Dabigatran-induced esophagitis masking esophageal cancer. Dig Liver Dis 53(2):251–252. https://doi.org/10.1016/j.dld.2020.05.019

    Article  PubMed  Google Scholar 

  24. Boehringer-Ingelheim Fachinformation Pradaxa Hartkapseln. Anhang I. Zusammenfassung der Merkmale des Arzneimittels. (Stand: 01/2023) 44.

  25. Desai J, Granger CB, Weitz JI, Aisenberg J (2013) Novel oral anticoagulants in gastroenterology practice. Gastrointest Endosc 78(2):227–239. https://doi.org/10.1016/j.gie.2013.04.179

    Article  PubMed  Google Scholar 

  26. Cox R, Roche E, Fairley S (2016) Novel oral anticoagulant drugs and severe oesophagitis dissecans. Intern Med J 46(12):1456–1457. https://doi.org/10.1111/imj.13275

    Article  CAS  PubMed  Google Scholar 

  27. Kono Y, Miyahara K, Nakagawa M (2020) A case of esophagitis induced by apixaban. J Gastrointestin Liver Dis 29(3):471. https://doi.org/10.15403/jgld-2685

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anna-Maria Tiefenthaller.

Ethics declarations

Interessenkonflikt

A.-M. Tiefenthaller, D. Schiller und R. Schöfl geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patient/-innen zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern/Vertreterinnen eine schriftliche Einwilligung vor.

Additional information

Hinweis des Verlags

Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tiefenthaller, AM., Schiller, D. & Schöfl, R. Von Weinsäure zu Weinbeere – eine ungewöhnliche Form der Ösophagitis. J. Gastroenterol. Hepatol. Erkr. 21, 30–32 (2023). https://doi.org/10.1007/s41971-023-00144-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s41971-023-00144-5

Navigation